AE

Loading...

Pacylex Pharmaceuticals completes its 'landmark' toxicology dosing

54 views

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jan 15, 2020

Pacylex Pharmaceuticals Inc CEO Michael Weickert spoke with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The biotech firm is is developing a precision medicine solution for multiple common cancers by targeting a cellular process called myristoylation to selectively kill cancer.

Comments are turned off
When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...